
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucids CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucids unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality...
Cardiovascular,plaque characterization,ffrct,ccta,heart disease,ct angiography,cct,stroke,and heart attck
Elucid operates in the Medical equipment manufacturing industry.
Elucid's revenue is 11m - 100m
Elucid has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.